Studying fatigue and walking in CMT type 1A
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study looks at how fatigue affects walking and balance in people with Charcot-Marie-Tooth type 1A. It compares patients with healthy volunteers to understand the impact. Participants will do walking and balance tests, and an exercise session on a stationary bike.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of CMT type 1A
- You are between 18 and 74 years old
- You can walk at least 200 metres without stopping (with or without a cane or walker)
- You have had a heart check-up (ECG and cardiac ultrasound) within the last 6 months, or are willing to get one before the study
- You do not have other types of neuropathy, severe leg joint problems, or a history of brain or nerve conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses motion analysis to understand walking and arm function in adults with certain neurological or metabolic diseases. The goal is to find patterns that help doctors better manage these conditions.
This study uses a small wearable sensor (like a fitness tracker) to see how active you are at home during your daily life. The goal is to better understand how CMT1A affects movement, which may help improve future care.
This study is looking for people with Charcot-Marie-Tooth disease (a nerve condition) and healthy volunteers to track long-term changes in the body. Researchers want to see if certain biomarkers (measurable signs) can help predict how CMT progresses over time.
This study examines how autonomic nerves (the nerves that control automatic body functions like heart rate and blood pressure) are affected in people with CMT (Charcot-Marie-Tooth disease), a genetic nerve disorder. Understanding this may help improve treatment and quality of life for CMT patients.
This trial looks for new markers of Charcot-Marie-Tooth 1A (CMT1A) early in the disease. Researchers hope to find signs that can help diagnose and track the disease better, which could lead to better treatments in the future.
This trial tests whether adding a special vibration device to an intensive rehab program helps improve balance in people with Charcot-Marie-Tooth disease type 1A. If you are between 18 and 65 and have mild to moderate leg weakness, you may be able to join.
Hear when a new Charcot-Marie-Tooth Type 1A trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.